Literature DB >> 11007714

Disability and quality of life in social phobia: epidemiologic findings.

M B Stein1, Y M Kean.   

Abstract

OBJECTIVE: Social phobia in clinical studies is vividly associated with extensive disability and reduced quality of life. It is difficult to obtain a clear portrayal of the impairment associated with social phobia in community samples. Furthermore, it has been unclear in prior studies to what extent indices were attributable to social phobia as opposed to comorbid major depression. The authors examined relevant data from the Ontario Health Survey Mental Health Supplement.
METHOD: The Ontario Health Survey Mental Health Supplement, a survey of more than 8,000 residents of Ontario, Canada, aged 15-64, used the University of Michigan Composite International Diagnostic Interview to assign DSM-III-R diagnoses. Several indicators of disability and quality of life were included. The authors compared these indices for persons with and without social phobia and adjusted where indicated for the effects of major depression and relevant sociodemographic factors.
RESULTS: Persons with social phobia were impaired on a broad spectrum of measures, ranging from dropping out of school to experiencing disability in one's main activity. They were also significantly more likely than persons without social phobia to rate themselves as "low functioning" on the Quality of Well-Being Scale and to report dissatisfaction with many aspects of life. Depressive comorbidity seemed to contribute only modestly to these outcomes.
CONCLUSIONS: Social phobia can be a serious, disabling anxiety disorder associated with marked reduction in quality of life. Impairment in social phobia is substantial, even in the absence of comorbid major depression.

Entities:  

Mesh:

Year:  2000        PMID: 11007714     DOI: 10.1176/appi.ajp.157.10.1606

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  116 in total

Review 1.  Unmasking social anxiety disorder.

Authors:  M B Stein; J M Gorman
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN).

Authors:  Laura Campbell-Sills; Emmanuel Espejo; Catherine R Ayers; Peter Roy-Byrne; Murray B Stein
Journal:  J Anxiety Disord       Date:  2015-09-18

3.  Social phobia: further evidence of dimensional structure.

Authors:  Erica Crome; Andrew Baillie; Tim Slade; Ayelet Meron Ruscio
Journal:  Aust N Z J Psychiatry       Date:  2010-11       Impact factor: 5.744

4.  A Tale of Two Threats: Social Anxiety and Attention to Social Threat as a Function of Social Exclusion and Non-Exclusion Threats.

Authors:  Julia D Buckner; C Nathan Dewall; Norman B Schmidt; Jon K Maner
Journal:  Cognit Ther Res       Date:  2010-10-01

Review 5.  Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.

Authors:  Richard A Hansen; Bradley N Gaynes; Gerald Gartlehner; Charity G Moore; Ruchi Tiwari; Kathleen N Lohr
Journal:  Int Clin Psychopharmacol       Date:  2008-05       Impact factor: 1.659

6.  Social context and the real-world consequences of social anxiety.

Authors:  Juyoen Hur; Kathryn A DeYoung; Samiha Islam; Allegra S Anderson; Matthew G Barstead; Alexander J Shackman
Journal:  Psychol Med       Date:  2019-08-19       Impact factor: 7.723

7.  Enhancing the Capacity of School Nurses to Reduce Excessive Anxiety in Children: Development of the CALM Intervention.

Authors:  Kelly L Drake; Catherine E Stewart; Michela A Muggeo; Golda S Ginsburg
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2015-07-14

8.  Social phobia in Swedish adolescents : prevalence and gender differences.

Authors:  Malin Gren-Landell; Maria Tillfors; Tomas Furmark; Gunilla Bohlin; Gerhard Andersson; Carl Göran Svedin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-29       Impact factor: 4.328

9.  Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

Authors:  Murray B Stein; Mark H Pollack; Alexander Bystritsky; Jeffrey E Kelsey; Richard M Mangano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

10.  Neural bases of social anxiety disorder: emotional reactivity and cognitive regulation during social and physical threat.

Authors:  Philippe R Goldin; Tali Manber; Shabnam Hakimi; Turhan Canli; James J Gross
Journal:  Arch Gen Psychiatry       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.